<DOC>
	<DOC>NCT01161602</DOC>
	<brief_summary>The purpose of this study is to determine if pumosetrag is effective in treating Gastroesophageal Reflux Disease (GERD) symptoms in patients who have a history of GERD symptoms and are currently taking an acid suppression therapy, such as a Proton Pump Inhibitor (PPI).</brief_summary>
	<brief_title>A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>Patients with history of Gastroesophageal Reflux Disease (GERD) symptoms (heartburn, regurgitation, acid taste in mouth). Between ages of 18 70 inclusive. Develop GERD symptoms following ingestion of a refluxogenic meal. Able to take a stable Proton Pump Inhibitor (PPI) regimen for duration of study. Understand and sign the informed consent form. Pregnant or lactating women. Allergic to pumosetrag or formulation excipients.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Symptoms of Gastroesophageal Reflux Disease (GERD)</keyword>
</DOC>